These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 570723)
1. [New insulins in diabetes therapy]. Morell B Schweiz Med Wochenschr; 1979 Mar; 109(10):362-5. PubMed ID: 570723 [TBL] [Abstract][Full Text] [Related]
2. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus. Harrower AD; Duncan LJ; Clarke BF Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249 [TBL] [Abstract][Full Text] [Related]
3. [The place of "monocomponent" insulins in diabetes mellitus therapy]. Teuscher A Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860 [TBL] [Abstract][Full Text] [Related]
4. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?]. Sachse G; Federlin K Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364 [TBL] [Abstract][Full Text] [Related]
5. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Andreani D; Iavicoli M; Colletti A; Menzinger G Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824 [No Abstract] [Full Text] [Related]
6. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications. Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720 [No Abstract] [Full Text] [Related]
7. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin]. Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003 [No Abstract] [Full Text] [Related]
13. Pork vs. beef insulin in control of diabetes mellitus--a case study. Cohen SS Am J Hosp Pharm; 1972 Oct; 29(10):874-6. PubMed ID: 4672658 [No Abstract] [Full Text] [Related]
14. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation]. Barbero L; Gamba S; Zanno C; Regis G; Bruni B Minerva Med; 1978 Apr; 69(21):1437-42. PubMed ID: 683547 [TBL] [Abstract][Full Text] [Related]
15. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir. Peterson GE Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343 [TBL] [Abstract][Full Text] [Related]
16. [The antigenicity of various new chromatographically purified depot insulin preparations]. Graber D; Fankhauser S Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic qualities of a lente preparation of swine insulins manufactured by Pharmachem]. Andreev D; Bozadzhieva E; Pampulov L; Penchev I; Uzunova B Vutr Boles; 1977; 16(6):59-66. PubMed ID: 341532 [TBL] [Abstract][Full Text] [Related]
18. The evolution of insulin therapy in diabetes mellitus. Heile M; Schneider D J Fam Pract; 2012 May; 61(5 Suppl):S6-12. PubMed ID: 22577636 [No Abstract] [Full Text] [Related]
19. [Novolet--a pen-device for insulin self-injection by disabled diabetics]. Kisch ES; Cohen Y; Arbeli S Harefuah; 1996 May; 130(9):604-5, 655. PubMed ID: 8794639 [TBL] [Abstract][Full Text] [Related]
20. U100 insulin and the general practitioner. Hartman LJ Aust Fam Physician; 1980 Jul; 9(7):464-8. PubMed ID: 6998449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]